UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 184

Sortiert nach

Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review

Clinical microbiology and infection, 2017-12, Vol.23 (12), p.916-923

2017

Volltextzugriff (PDF)

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

Clinical microbiology and infection, 2017-12, Vol.23 (12), p.935-940

2017

Volltextzugriff (PDF)

Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal

BMC infectious diseases, 2017-08, Vol.17 (1), p.566-566, Article 566

2017

Volltextzugriff (PDF)

Multiple hepatic and brain abscesses caused by Parvimonas micra: A case report and literature review

Anaerobe, 2021-06, Vol.69, p.102366-102366, Article 102366

2021

Volltextzugriff (PDF)

Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

Infection, 2024-06, Vol.52 (3), p.737-765

2024

Volltextzugriff (PDF)

The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro

Clinical microbiology and infection, 2019-07, Vol.25 (7), p.906.e1-906.e7

2019

Volltextzugriff (PDF)

Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease

European review for medical and pharmacological sciences, 2021-03, Vol.25 (5), p.2418

2021

Volltextzugriff (PDF)

Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor

Clinical microbiology and infection, 2016-11, Vol.22 (11), p.946.e1-946.e8

2016

Volltextzugriff (PDF)

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia

Journal of antimicrobial chemotherapy, 2015-06, Vol.70 (6), p.1865-1873

2015

Volltextzugriff (PDF)

Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy

Clinical microbiology and infection, 2015-03, Vol.21 (3), p.288.e5-288.e7

2015

Volltextzugriff (PDF)

HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications

European review for medical and pharmacological sciences, 2012-10, Vol.16 (11), p.1473

2012

Volltextzugriff (PDF)

Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries

Expert review of pharmacoeconomics & outcomes research, 2019-09, Vol.19 (5), p.581-599

2019

Volltextzugriff (PDF)

Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals

European journal of clinical microbiology & infectious diseases, 2016-09, Vol.35 (9), p.1531-1539

2016

Volltextzugriff (PDF)

Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14

Journal of antimicrobial chemotherapy, 2017-10, Vol.72 (10), p.2837-2845

2017

Volltextzugriff (PDF)

HIV Coreceptor Tropism in Paired Plasma, Peripheral Blood Mononuclear Cell, and Cerebrospinal Fluid Isolates from Antiretroviral-Naïve Subjects

Journal of Clinical Microbiology, 2011-04, Vol.49 (4), p.1441-1445

2011

Volltextzugriff (PDF)

Gain of positively charged amino acids at specific positions of HBsAg C-terminus tightly correlates with HBV-induced hepatocellular carcinoma by altering the structural folding of this domain

Journal of hepatology, 2017, Vol.66 (1), p.S684-S684

2017

Volltextzugriff (PDF)

In HBeAg-negative chronic HBV infection, HBsAg levels profoundly vary among different HBV-genotypes and can be influenced by the degree of HBsAg variability: can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?

Journal of hepatology, 2017, Vol.66 (1), p.S470-S470

2017

Volltextzugriff (PDF)

The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification

Journal of hepatology, 2017, Vol.66 (1), p.S681-S681

2017

Volltextzugriff (PDF)

A High Density of Mutations within HLA Class I and II HBsAg/RT Epitopes Characterizes HBV Variants Emerging during Immune-Suppression Driven HBV Reactivation

Journal of hepatology, 2016, Vol.64 (2), p.S376-S377

2016

Volltextzugriff (PDF)

Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA

Journal of hepatology, 2017, Vol.66 (1), p.S250-S251

2017

Volltextzugriff (PDF)

HBV-HDV Co-Infection Constrains HBV Genetic Evolution in HBsAg

Journal of hepatology, 2016, Vol.64 (2), p.S355-S355

2016

Volltextzugriff (PDF)

Dasabuvir and Ombitasvir/Paritaprevir/Ritonavir with or without Ribavirin in Patients with HIV-HCV Coinfection: Real Life Interim Analysis of an Italian Multicentre Compassionate Use Program

Journal of hepatology, 2016, Vol.64 (2), p.S763-S763

2016

Volltextzugriff (PDF)

P0580 : Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome

Journal of hepatology, 2015-04, Vol.62, p.S533-S533

2015

Volltextzugriff (PDF)

P0625 : A hyper-glycosylation of HBV surface major hydrophilic region characterizes HBV reactivation driven by immunosuppression and affects HBsAg recognition in vitro

Journal of hepatology, 2015-04, Vol.62, p.S553-S553

2015

Volltextzugriff (PDF)

In HBeAg-negative chronic HBV infection, HBsAg levels profoundly differ among HBV-genotypes and can be affected by the extent of HBsAg variability: Can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?

Digestive and liver disease, 2017-02, Vol.49 (1), p.e45-e45

2017

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(170)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(108)
Humans
(102)
Infectious Diseases
(78)
Male
(65)
Female
(61)
Biological And Medical Sciences
(58)
Microbiology
(51)
Adult
(50)
Medical Sciences
(50)
Middle Aged
(45)
Virology
(42)
Hiv Infections - Drug Therapy
(41)
Human Immunodeficiency Virus
(36)
Human Viral Diseases
(33)
Viral Diseases
(33)
Aids/hiv
(25)
Immunology
(25)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(25)
Hiv
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal

Multiple hepatic and brain abscesses caused by Parvimonas micra: A case report and literature review

Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro

Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease

Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia

Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy

HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications

Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries

Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals

Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14

HIV Coreceptor Tropism in Paired Plasma, Peripheral Blood Mononuclear Cell, and Cerebrospinal Fluid Isolates from Antiretroviral-Naïve Subjects

Gain of positively charged amino acids at specific positions of HBsAg C-terminus tightly correlates with HBV-induced hepatocellular carcinoma by altering the structural folding of this domain

In HBeAg-negative chronic HBV infection, HBsAg levels profoundly vary among different HBV-genotypes and can be influenced by the degree of HBsAg variability: can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?

The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification

A High Density of Mutations within HLA Class I and II HBsAg/RT Epitopes Characterizes HBV Variants Emerging during Immune-Suppression Driven HBV Reactivation

Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA

HBV-HDV Co-Infection Constrains HBV Genetic Evolution in HBsAg

Dasabuvir and Ombitasvir/Paritaprevir/Ritonavir with or without Ribavirin in Patients with HIV-HCV Coinfection: Real Life Interim Analysis of an Italian Multicentre Compassionate Use Program

P0580 : Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome

P0625 : A hyper-glycosylation of HBV surface major hydrophilic region characterizes HBV reactivation driven by immunosuppression and affects HBsAg recognition in vitro

In HBeAg-negative chronic HBV infection, HBsAg levels profoundly differ among HBV-genotypes and can be affected by the extent of HBsAg variability: Can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?

Suchergebnisse filtern